ASHPOfficial

This podcast series will highlight the recommended approach to managing patients with peripheral arterial disease from screening to therapy selection. Appropriate risk factor modification and therapy is essential in PAD to optimize care by reducing cardiovascular morbidly and mortality.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The COVID-19 pandemic has required pharmacist preceptors to rethink how to deliver APPE and resident rotations within our health systems.  This podcast will explain a successful model implemented within an ambulatory care setting. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will focus on leading through rapid change as a result of Covid-19. The main topics include change within various pharmacy services, including hospital closures, mergers and acquisitions, restructuring pharmacist responsibilities and modification or elimination of current pharmacy services. In addition to discussing changes, this podcast will discuss lessons learned, opportunities that arose and efforts to reactivate services that were discontinued. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join our content matter experts from the 2020 Midyear Clinical Meeting as they identify optimization strategies for pain and sedation medication management in mechanically ventilated COVID-19 patients, describe the patient-specific considerations when optimizing pain and sedation management affected by drug shortages and discuss patient-specific challenges associated with medication shortages for COVID-19 patients requiring mechanical ventilation.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

With the increased use of direct-activity oral anticoagulants (DOACs) over the last decade, it is inevitable that emergency departments are seeing more patients with DOAC-related bleeding. Get an inside look at pharmacists’ strategies for optimizing reversal of DOAC-related bleeding in various ED settings.

To learn more about this initiative, visit www.ashpadvantage.com/stopdoacbleed

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast series will highlight the recommended approach to managing patients with peripheral arterial disease from screening to therapy selection. Appropriate risk factor modification and therapy is essential in PAD to optimize care by reducing cardiovascular morbidly and mortality.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Elyse Macdonald shares her experiences and best practices for combining remote work and patient care and how to continually engage staff during the transition from and back to working in person. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The goal of the human microbiome project is to better understand the microbial components of our bodies and how this interface between micro-organisms and humans contribute to normal physiology and disease predisposition.  In this podcast, we will explore a classic microbiome disruption disease, namely C difficile infection.  Looking at C diff infection through the lens of the microbiome, we will explore the pathophysiology, treatment, and future of this important and devastating infectious disease.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The human microbiome is arguably one of the most ambitious scientific projects conducted by mankind of all time.  The goal is to better understand the microbial components of our bodies and how this interface between micro-organisms and humans contribute to normal physiology and disease predisposition.  The goal of this podcast will be an informative discussion on the interactions between bugs and bodies.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast highlights the essentials from the 2020 Midyear Clinical Meeting presentation and will help pharmacists develop strategies to overcome common barriers seen with immunization program, recommend adaptable pharmacy workflows for inpatient and outpatient pharmacy systems to increase immunization rates and assess pharmacy practice implications of current COVID-19 vaccine developments. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.